Synopsis of recent research by authors named "Xuebo Pan"
- Recent research by Xuebo Pan focuses on the role of fibroblast growth factors, particularly FGF21 and FGF10, in various conditions such as liver injury, prostate cancer, and metabolic diseases, exploring mechanisms like autophagy activation and energy metabolism regulation.
- Pan's studies demonstrate the therapeutic potential of targeting FGF signaling pathways in diseases like acetaminophen-induced liver injury and prostate cancer, highlighting pathways involving Sirt1 and iron homeostasis.
- Additionally, the research emphasizes the intersection of metabolic pathways and inflammation, showing how genetic variants and cytokine levels relate to conditions like alcohol dependence and type 2 diabetes, indicating a broad impact on health and disease management.
